A co-ordinated series of vascular events underlie the generation of a penile erection. The control and regulation of this simple event is, in fact, a complex of interactions occurring at multiple levels. Many of these individual pathways and responses have been studied extensively. The understanding of the necessity for the integration between the individual pathways into a complex of series and parallel coupled mechanisms provides a rationale for the development of a framework of multiple and overlapping systems. This paper sets out some of the principles of integrated and balanced control of vasodilation and vasoconstriction in the penis. In addition, the role of growth induction and regression and the importance of time as a factor in studying penile structure and function is discussed.
Introduction
A signi®cant number of the underlying problems in clinical erectile dysfunction relate to disturbances in`vascular' mechanisms. The contribution made by different vascular control systems to the regulation of penile erection in normal and pathophysiological states has been studied both by using conventional techniques developed for normal vascular biology (NVB) studies and in specialized studies developed to pursue putative penile-speci®c mechanisms. Recently there has been a further expansion in research activities in erectile function because of the potential for new therapeutic strategies which can be brought into clinical practice.
The progression of vascular events that underlie penile erection has consequences related to both hemodynamic and structural endpoints. It involves a complex interaction of systems that work together and in opposition. The multiplicity of control systems is not surprising for any system important to survival since relying on a single system would leave the organism vulnerable to extinction by a single failure of ontogeny. The natural consequence of this reasoning is that associated with successful phylogeny, by de®nition, there must be multiple and overlapping systems governing erectile function. Extending this concept further, successful systems are likely to be repeated in multiple tissue and organ systems. This second concept suggests that we should focus research on erectile function towards elucidating vascular mechanisms with proven ef®cacy in other critical organ systems such as the brain, heart and kidney. That is, the principles of NVB should provide a useful conceptual framework on which to base an assessment of the quantitative contributions of different systems in the erectile process.
As is recognized in NVB, dynamic regulation of any system can be successful only if it can respond appropriately to stimuli in both directions. Thus, the operating point of any control system ideally should reside on the steep portion of the stimulusresponse relationship, thereby providing the maximum gain to sustain homeostasis. It is not surprising that most successful control systems can be modelled as a sigmoidal or a logistic function relation; demonstrating a threshold stimulus for initial response, a steep middle section and a saturable peak response characteristic. This model of a control system de®nes the process whereby small perturbations away from an operating point are corrected with optimal ef®ciency and yet within de®ned limits. In the penis one objective of the control systems which regulate penile arterial¯ow is to permit a small neural signal to achieve tumescence despite changes in homeostatic conditions within certain limits.
A more obvious rationale for the requirement of multiple and overlapping systems in the regulation of penile erection is based on experimental evidence. A wide range of scienti®c data supports the potential role for many factors which can in¯uence vascular tone in general as well as in the penis. The most dif®cult research goal is to assign appropriate involvement of each process present in the overall function of a system. Thus, a major constraint on exposing the quantitative role of different circulatory control processes is imposed by the fact that experimental conditions are usually designed to isolate a single system. The experimentation performed to deal with the mechanisms of erection is no exception.
The physiological basis of penile erection: interactions between structure and function
The stimulus for a physiological erection originates in the central nervous system. A fully functional penile erection requires co-ordinated change in output from various levels of the central nervous system and at least three sets of peripheral nerves (thoracolumbar sympathetic, sacral parasympathetic, and pelvic somatic). At the level of penile tissue, localization of sympathetic and parasympathetic as well as non-adrenergic, non-cholinergic nerve terminals has indicated the potential involvement of numerous neurotransmitter systems. 1 An excellent overall account of the neural processes involved in the production of a penile erection can be found in the review by deGroat and Steers.
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A penile erection is known to be dependent upon the balance and integration between structural (vascular and extracellular matrix) and functional control systems (neural, local factors and humoral/ endocrine). The nature of the balance between these contributing in¯uences is ultimately expressed as vasodilation and penile tumescence, as long as there is an adequate level of systemic blood pressure and an appropriate hormonal milieu.
The penile vascular components that have a signi®cant role in regulating erectile function are the pudendal arterial system, the cavernous arteries, the corpora cavernosa and the corpus spongiosum and glans. There is usually one main supplying endartery per cavernosal body, which branches off from the corresponding internal iliac artery. There are a number of studies showing that there is structural variability in this portion of the vascular tree but our primary discussion is concerned with the points of control and principles involved and not with minor anatomic heterogeneity. This feeder artery branches to become the deep penile artery which has at least two types of branches within the cavernosa: helicine arteries which direct¯ow to lacunar spaces and vessels which direct¯ow for nutrient supply via capillaries.
It is well established that an erection requires a neurally mediated (autonomic) vasodilation of both the penile arterial blood vessels and the trabecular meshwork. 3 The combined dilatation facilitates an initial rapid increase in arterial in¯ow into the cavernous bodies of the penis promoting tumescence followed by a phase of decreased in¯ow resulting from the unstable phase involving the occlusion of sub-tunical veins and full rigidity, namely the veno-occlusive mechanism, which imposes a dramatic increase in in¯ow resistance. Conversely, detumescence is likely mediated, at least in part, by activation of the sympathetic nervous system 1, 3 as well as removal of active vasodilator tone and in addition, may involve changes in local systems.
Penile control systems
At the level of the penis the neural control systems for erection are conventionally described under the three headings: adrenergic, cholinergic and nonadrenergic non-cholinergic (NANC). Adrenergic nerve ®bres and localization of norepinephrine containing nerve terminals can be found in the corpora 4 and the contractile properties of a-adrenergic agonists are established unequivocally. 5 Postsynaptic vasoconstrictor effects appear to be predominantly mediated by a 1 -adrenoceptors acting directly and a 2 -adrenoceptors appear to have some role in pre-synaptic modulation. Other substances such as neuropeptide Y may also play a role as a vasoconstrictor co-transmitter.
Previously, parasympathetic nerves were thought to be the primary nerves responsible for the vasodilation of an erection, although the in vitro effects of acetylcholine were disappointing. 5, 6 In addition, intracorporal injection of acetylcholine (ACh) alone is not particularly effective in causing an erection and, furthermore, atropine does not block physiological erections. Thus, this type of evidence implies that the function of cholinergic nerves is to act as modulators of neural function as opposed to having a primary involvement in vasodilation.
This lack of evidence implicating acetylcholine as a primary player initiated a change in focus towards recognising NANC innervation as a pre-eminent player in erectogenesis. Various studies revealed that both calcitonin gene related peptide (CGRP) 7 and vasoactive intestinal polypeptide (VIP) 8 could be found in NANC nerve terminals and act as the NANC neurotransmitter substance. However, based on ®ndings that the effects of these substances could not completely account for erections the search continued for other substances.
Based on the results of Ignarro et al 9 and others, 10 nitric oxide (NO) became the new centrepiece of investigations into determining`the mediator' of erection. Researchers have demonstrated that NO has the capacity to be both a mediator of corporal relaxation as well as having involvement in the CNS initiating mechanism of erection. 11 The concept that NO plays a critical role as a mediator of erections has developed, for the most part, as a consequence of experiments in which nitric oxide synthase (NOS), the enzyme which regulates the production of nitric oxide, is blocked. The results of these studies involving administration of NOS inhibitors, speci®cally with acute treatments, has shown that animals responded with diminished or no erectile responses. 11 In some of these studies the blockade of erections acutely was shown using electrical stimulation of the cavernosal nerve in anesthetized animals whereas in others the stimulus was by centrally-mediated erections in vivo.
11 Other studies, providing supporting evidence have localized nitric oxide synthase (NOS) to the corpus cavernosum using NADPH-diaphorase staining. 12 One interpretation of this data is that removal of NO produces an environment which is exquisitely sensitive to vasoconstrictor stimuli. The ®nding (Figure 1 ) that the sensitivity to an a-adrenoceptor stimulus is markedly enhanced is consistent with this concept. Further analysis of the mechanism by which this sensitization occurs has revealed that the mechanism involves a completely novel enhancement via the local vasoconstrictor endothelin. 13 Thus, a series of ®ndings from our own research have seriously eroded our con®dence in the concept that NO is`the primary' initiator of erection whereas, in contrast, other data suggests that NO plays an important role. The methodology that was essential in establishing the scope of this concept in vivo utilized the apomorphine-induced erection model. 13 This model allows the investigator to test repetitively for erectile responses in conscious rats. In the ®rst part of the studies, using this methodology in conscious rats, we determined erectile responses after administering doses of L-NAME which dramatically lowers both neuronal and endothelial NOS activity throughout the body.
14 Surprisingly, we found that there was a complete return of apomorphine-induced erectile responses within hours of the blockade. This result demonstrates that erections in normal rats do not have an obligatory requirement for NO, at least in the subacute phase.
In a second study, we further investigated the mechanism by which NOS blockade produces a marked decrease in erections in the acute phase of L-NAME treatment as shown by Argiolas 11 and ourselves.
14 Thus, we applied the concept that a key adaptive response that occurs after NOS blockade is the dramatic up-regulation of the vasoconstrictor actions of endothelin. 15 To test the applicability of this concept in the penis we administered intravenously an ET receptor antagonist to rats prior to the L-NAME treatment. 16 The prior pharmacological blockade of ET receptor activation fully prevented any decrease in the apomorphine-induced erection responses that normally occurs following acute NOS blockade. Thus, using the apomorphine-induced model of erectile function we have been able to demonstrate that multiple control mechanisms must be involved under these conditions. The concept of multiple and overlapping control systems in the penis is presented in schematic form in Figure 2 . Taken together, these ®ndings demonstrate that in order to quantify the involvement of each of the multiple control mechanisms an understanding of the role of Figure 1 These data are from penile perfusion experiments using an established methodology. The traces show (A) a cumulative concentration-response effect following additions of an a-adrenoceptor agonist (methoxamine), (B) an enhanced vasoconstrictor response induced by removal of endogenous NO (L-NAME) and an a-adrenoceptor agonist (methoxamine) individually at sub-pressor doses and (C) the overall shift in the concentration-response curve resulting from this`priming' effect on vasoconstriction.
local, neural and humoral systems alone and concert, acutely, and during and after chronic homeostatic adjustments. A key feature of this concept is the shift in paradigm for the role of NO. 16 It is not surprising that there had already been numerous indications that the`only NO theory' was insuf®cient to explain all erectile mechanisms. Two decades of research have demonstrated the functional presence of other vasodilator factors such as VIP, prostanoids and acetylcholine in the penile vasculature. 17, 18 Also, and perhaps more speculative is the putative role for carbon monoxide (CO), another activator of soluble guanylyl cyclase, a small molecule which is generated upon heme degradation by the heme oxygenases. 17, 19 This latter point simply suggests that we have not yet fully accounted for the range of systems that might be involved under normal and abnormal conditions of erectile function. The concept which emphasizes a framework of multiple and overlapping control systems will allow for inclusion of new substances and processes as they are discovered.
The multiplicity of control: macro to micro
Most of the parts of the conceptual framework may already be in place. We already have a substantial body of knowledge relating to the hemodynamic events that lead to an erection. 3 NVB has already provided a concept of the roles played by many systems acting as neuroeffector, humoral substances and local acting intracrine, paracrine and autocrine factors. The integration of these mechanisms, which occurs following the central initiation of an erectogenic stimulus, to cause changes such as the increased in-¯ow of arterial blood and the rapid relaxation of corpora cavernosa must be further explored.
One area of research in which we do not yet have enough knowledge relates to the molecular basis of vascular control. The responses of blood vessels to vasoactive agents can be profoundly different depending on the location, size, and function of the vascular bed and whether the agents act through the cAMP or cGMP systems.
20±22 A corollary to the overall hypothesis for the design of control, that there is multiplicity and overlap, also appears in the molecular basis for vascular control mechanisms in the regulation of erectile function. Accordingly, the responses to vasoactive agents acting on penile blood vessels via cyclic nucleotide signaling pathways or other systems are likely to demonstrate plasticity as well as heterogeneity in different physiological and pathophysiological states.
The cyclic nucleotide systems involved in regulating penile erection will likely demonstrate on a molecular level the same characteristic principles of regulation that have been identi®ed already in other systems. Balance, interaction, multiplicity and time dependence. All of the physiologic and pharmacological agents that regulate changes in penile vascular function listed in the preceding sections do so by either relaxing or contracting vascular smooth muscle cells (VSMC) 20±22 . Moreover, these vasoactive agents can bring about changes in the function of the penile vasculature by interacting directly with the VSMC, or indirectly, by actions which lead to the release of vasoactive agents from vascular endothelial cells (EDRF; nitric oxide (NO) and prostacyclin (PGI2)). 23, 24 In all vascular beds studied, including the penile vasculature, the relaxant effects of NO are thought to be mediated by activation of soluble guanylyl cyclase resulting in an increase in intracellular cGMP levels in VSMC. 27 Similarly, most of the effects of PGI2 and the other activators of adenylyl cyclase which modulate vascular function are thought to be mediated by an increase in VSMC cAMP levels by way of activation of adenylyl cyclase. 21 In large and small arteries, the relative importance of the cAMP and cGMP systems appears to be different. 25, 26 Indeed, whereas NOmediated relaxations seem to be more important in large arteries, PGI2 is a potent vasorelaxant in smaller arteries. 27 The relative importance of activation of adenylyl cyclase or guanylyl cyclase in regulating the various blood vessels which constitute the penile vasculature is unknown and the relative importance of these two systems in controlling these blood vessels needs to be addressed.
It is widely acknowledged that large and small blood vessels play very different roles in the circulatory system and that the responses to different vasoactive agents that act through the cAMP or cGMP systems are also different in different sized blood vessels. 10,20±24 There is no general consensus as to the molecular basis of this phenomenon. Accordingly, it is likely that the components of the intracellular signalling systems that control their various functions will be different (for example receptors, coupling, transducers, metabolic en- zymes). The differential expression in blood vessels of speci®c receptors is one possible explanation for differences in responses to vasoactive agents. Differential expression of many receptors (for example adrenergic, muscarinic, purinergic, serotonergic, prostanoid and endothelin) for agents that either stimulate or inhibit adenylyl cyclase activity in VSMC and endothelial cells has been reported. 28 Thus, vasoactive agents, either circulating or released locally, can have selective effects on speci®c vasculatures expressing the relevant receptors. However, it is now acknowledged that receptor heterogeneity alone does not account for all differences in vascular responses. This concept is consistent with the ®nding that agents that act at sites distal to the receptor (namely forskolin, NaF, NO) also have selective effect on the function of certain blood vessels. The understanding of post-receptor events in the penile vasculature is in its infancy.
The balancing act of control systems: short term to long term consequences
The penis has a specialized circulation and is one of a small number of organ systems that utilizes countervailing neural control systems acting to dynamically regulate function (tumescence and detumescence). To fully elucidate quantitative roles played by the various countervailing systems both in clinical and experimental settings it must be emphasized that there is a critical balance and interdependence that is essential for normal function. Importantly, an aspect of erectile dysfunction that has received very little attention has been the assessment of long term adaptive changes in the structure of the penis that may result from an alteration in this critical balance (Figure 3) .
The importance of balance between extra-penile and intra-penile regulatory systems can be seen in this brief-example: Adrenoceptor activation is known to antagonize the penile smooth muscle relaxation which is essential to erection just as activation is a major player in detumescence. Stress is widely known to induce adrenoceptor activation. In animals, we have shown that close proximity of other rats, can induce stress and can prevent a rat having an erection in response to a pharmacological. 29 Thus, high sympathetic activity is considered to be a contributory factor to ED in man. We have also shown, in animal studies, that the stressinduced decrease in erections is mimicked by the use of adrenoceptor agonists acutely in freely moving rats. These studies have shown that it is the acute nature of the blood pressure change (namely hemodynamic instability) that proves the point because chronic blood pressure changes permit sympathetic normalization and resumption of normal erectile activity in experimental rats. In fact, as described above, even if the blood pressure change (elevation) is caused by NOS inhibition with the arginine analog, L-NAME, not adrenoceptor agonists, the same results are seenÐacute depression of erectile response but recovery within 4 h.
Current clinical management of this unique vascular bed, in a man complaining of ED, consists often of injecting the penis with powerful vasodilator agents (or implanting a prosthesis) to get an erection. The ®nding that erectile tissue from men undergoing prosthesis implantation is capable of à normal' vascular response in vitro 10 is a consequence of interpreting erectile failure as being necessarily of penile origin, the penocentric viewpoint. Functional tissue is being treated in dysfunctional men because the treatment works regardless of the actual cause of the clinical failureÐa therapeutic sledgehammer. If we can understand the contribution of the regulatory systems we will be able to identify and treat speci®c de®cits. For instance, tonic vasodilator failure allows for normal levels of adrenoceptor stimulation to have major constrictor effect in the penile vasculature ( Figure  1 )Ðto understand this concept requires a simultaneous quantitative and comparative analysis of the potential interactions within and between the vasodilator and vasoconstrictor systems. A therapeutic strategy which may prove overreaching is that enhancements in resting vasodilator tone should improve the likelihood of successful physiological erection.
These processes are always a blend of competing, overlapping and opposing systems. A maximal direct pharmacological vasodilator stimulus may not produce an erection in a penis driven by the high sympathetic nervous system activity state induced by fear. Thus it is not surprising that alterations in blood¯ow and vascular dynamics whether produced by decreased cardiac output, Figure 3 The balance between vasoconstrictor and vasodilator in¯uences represents a complex mechanism represented by a simple endpoint: tumescence or detumescence.
re¯ex sympathetic hyperactivity, atherosclerosis, untreated hypertension, or antihypertensive medication produce profound effects on the ability of thē accid penis to be transformed into the erect state.
The temporal aspect of penile regulation by vasoconstrictor and vasodilator systems
An example of the consequences of an imbalance in critical systems comes from the understanding of pathological changes in the cardiovascular system. In studies assessing the etiology of hypertension much of the initial work focused on causes and mechanisms which were`quick-acting'. In fact, the actual rise in blood pressure was slow and ultimately larger than could be accounted for by the simple involvement of the`initiating mechanism'.
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In this work it became essential to understand the roles played by a series of changes in slower acting vasoconstricting and vasodilating systems involving structural adaptive mechanisms in the cardiovascular system. Applied speci®cally to erectile dysfunction this concept teaches that we must understand the contribution of changes both in structure and function over time in this pathological process (Figure 4) . However, the roles played by different stimulatory and inhibitory factors, including mechanical forces, vasoactive substances, growth factors, endocrine and autocrine hormones, in mediating vascular growth responses in vivo have not been clearly identi®ed. In particular, the involvement, potency and time course (acute, short term and chronic) of each of the various factors contributing overall to function and growth has not been fully characterized. For example, angiotensin II and catecholamines have been widely investigated both as controllers of the circulation as well as agonists able to promote growth of cardiovascular tissue. On the other hand, nitric oxide (NO) is a well described vasodilator that can act as an anti-trophic factor.`Newer' local vasoconstrictor systems, such as that represented by endothelin (ET), have not been studied adequately with regard to cardiovascular growth induction. Another level of complexity of the regulation has come from the recent ®ndings that the endogenous vasodilator systems, in particular NO, not only have the capacity to provide an offsetting balance against other constitutively expressed vasoconstricting and trophic signaling processes, for example NE, Ang II, AVP (as in Figure 2 ), but they also play a primary role in blocking the expression of an endogenous vasoconstrictor and trophic system, endothelin (Figure 2 ). In areas of normal' circulation, constitutive levels of NO prevent any physiological amounts of ET from contributing. In the penis, and in other portions of the circulation, the complexity of the interaction between short term adjustments in functional control systems and the long term consequences lies in the capacity of these systems to induce both functional and structural adaptive processes which alter the tissue response characteristics (as in Figure  4 ).
Conclusions
Based on the evidence that multiple control systems are present, have function and can plausibly provide appropriate regulation of vascular status in the penis it is not necessary to adhere to the concept that NO alone is obligatory for erections in the rat. Other vasodilator systems play important roles in the production of neurally mediated erections although their role both qualitatively and quantitatively remains to be fully established. Over the last decade investigators have found that vasodilators such as ACh, VIP, CGRP, and various prostanoids have been localized to the corpus cavernosum and have been shown to have the capacity to produce penile smooth muscle relaxation. Our demonstrations that erections occur in the absence of NOS suggests that one or more of these systems is not merely present but has an important role as a parallel pathway. Indeed, it is almost inevitable that such a vital reproductive function should have such plasticity, namely that one or more pathways has the capacity to adapt and assume a prominent dilator role when NO production is diminished to ensure that this element of reproductive capacity is maintained. Accordingly, one of the overall goals of erectile function research is to determine how these systems Figure 4 The relationship between changes in vascular tone and structure or growth status is determined by the duration and magnitude of the stimulus and the rate of activation of the response. This principle, that short term tonic changes will be incorporated into long term structural changes, is critical to understanding normal vascular biology (NVB) of which penile vascular function is specialized subset.
change both qualitatively and quantitatively to maintain erectile function throughout periods of adverse systemic¯uctuations. It may well be that NO is a primary player in normal conditions but it probably also can have a lesser role as a modulator or regulator when there is a change in the contribution of`other' dilator and constrictor pathways. For example, under conditions of NOS blockade it may be that, at the tissue level, we might ®nd an ampli®ed vasodilator response to VIP, but not to other agonists, which can be accounted for by a speci®c increase in expression of adenylyl cyclase coupled to VIP receptors. Such speculation, and others of potential research and clinical impact, are logical when the inevitability of multiplicity, redundancy, balance and plasticity has been considered. Finally, an area of erectile function research that needs to be addressed relates to changes to the regulation of growth and regression of the structural components of the erectile mechanism. Future studies are required to elucidate the trophic and anti-trophic roles of vasoconstricting and vasodilating systems as well as the regulation of growth factors.
